BDBM663066 2-((2S)-1-acryloyl-4-(8- fluoro-2-((2R,7aS)-2- fluorotetrahydro-1H- pyrrolizin-7a(5H)- yl)methoxy)-7-(1,1a,6,6a- tetrahydrocyclopropa[a] inden-5-yl)pyridino[4,3- d]pyrimidin-4-yl)piperazin-2- yl)acetonitrile, 1st eluting isomer::US20240109893, Example 877

SMILES F[C@H]1CN2CCC[C@@]2(COc2nc(N3CCN([C@@H](CC#N)C3)C(=O)C=C)c3cnc(c(F)c3n2)-c2cccc3C4CC4Cc23)C1

InChI Key InChIKey=UPJZUKKSWTWBPO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 663066   

TargetGTPase KRas [G12C](Human)
Shanghai Kechow Pharma

US Patent
LigandPNGBDBM663066(2-((2S)-1-acryloyl-4-(8- fluoro-2-((2R,7aS)-2- flu...)
Affinity DataIC50: 0.710nMAssay Description:1. Serially 4×-diluted compounds (10 concentration points in total) were separately premixed with KRAS G12C-GDP (ICE, Kras 20191018) in a reaction bu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent